Differently, γ-syn, first identified as breast cancer specific gene 1 (BCSG1) [8], is involved in tumor pathogenesis and correlates with adverse outcomes in breast [8,17], colon [18,19], pancreatic [20] and ovarian cancer [17]. This evidence concerns the gene SNCG and ovarian cancer.